ATE318601T1 - Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten - Google Patents

Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten

Info

Publication number
ATE318601T1
ATE318601T1 AT02765268T AT02765268T ATE318601T1 AT E318601 T1 ATE318601 T1 AT E318601T1 AT 02765268 T AT02765268 T AT 02765268T AT 02765268 T AT02765268 T AT 02765268T AT E318601 T1 ATE318601 T1 AT E318601T1
Authority
AT
Austria
Prior art keywords
compositions
xylometazoline
running
treatment
salt
Prior art date
Application number
AT02765268T
Other languages
English (en)
Inventor
Hanne Anette Moesgaard
Karin Lowenstein Christensen
Original Assignee
Nycomed Danmark Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Danmark Aps filed Critical Nycomed Danmark Aps
Application granted granted Critical
Publication of ATE318601T1 publication Critical patent/ATE318601T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
AT02765268T 2001-09-18 2002-09-18 Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten ATE318601T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200101356 2001-09-18

Publications (1)

Publication Number Publication Date
ATE318601T1 true ATE318601T1 (de) 2006-03-15

Family

ID=8160714

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02765268T ATE318601T1 (de) 2001-09-18 2002-09-18 Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten

Country Status (21)

Country Link
US (2) US7652030B2 (de)
EP (2) EP1446119B1 (de)
JP (1) JP4500045B2 (de)
KR (1) KR100810872B1 (de)
CN (1) CN1290502C (de)
AT (1) ATE318601T1 (de)
BR (1) BRPI0212586B8 (de)
CA (1) CA2460140C (de)
DE (1) DE60209511T2 (de)
DK (1) DK1446119T3 (de)
EA (1) EA008165B1 (de)
ES (1) ES2259098T3 (de)
HK (1) HK1067984A1 (de)
HU (1) HU226527B1 (de)
MX (1) MXPA04002500A (de)
NO (1) NO334441B1 (de)
NZ (1) NZ531792A (de)
PL (1) PL208686B1 (de)
PT (1) PT1446119E (de)
SI (1) SI1446119T1 (de)
WO (1) WO2003024433A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
HU226527B1 (hu) * 2001-09-18 2009-03-30 Nycomed Danmark Aps Készítmények nátha kezelésére
TWI359675B (en) * 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
EP1713472A2 (de) * 2004-02-06 2006-10-25 MEDA Pharma GmbH & Co. KG Behandlung von rhinitis mit anticholinergika allein in kombination mit antihistaminen, phosphodiesterase-4-hemmern oder corticosteroiden
WO2005084330A2 (en) * 2004-03-02 2005-09-15 Synergia Pharma, Inc. Compositions and methods for treating nasal congestion
DE102004049008A1 (de) * 2004-10-05 2006-04-06 Merck Patent Gmbh Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur
NZ555693A (en) * 2004-12-27 2010-10-29 Eisai R&D Man Co Ltd Matrix type sustained-release preparation containing donepezil
DE102006023770A1 (de) * 2006-05-20 2007-11-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Treibgasfreie Aerosolformulierung für die Inhalation
EP2077132A1 (de) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Abgabevorrichtung, Aufbewahrungsvorrichtung und Verfahren zur Abgabe einer Formulierung
US20090270472A1 (en) * 2008-04-25 2009-10-29 Kenneth Gould Method to use oxymetazoline to interrupt the development of the common cold syndrome
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
EP3508239B1 (de) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
UA107097C2 (en) 2009-11-25 2014-11-25 Бьорінгер Інгельхайм Інтернаціональ Гмбх Dispenser
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
EP2585151B1 (de) 2010-06-24 2018-04-04 Boehringer Ingelheim International GmbH Vernebler
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
WO2014158118A1 (en) * 2013-03-29 2014-10-02 Santa Farma İlaç Sanayi̇ A.Ş. Suspension composition containing ipratropium and oxymetazoline
WO2014158119A1 (en) * 2013-03-29 2014-10-02 Santa Farma İlaç Sanayi̇ A.Ş Aqueous solution composition containing ipratropium and oxymetazoline
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
WO2015018904A1 (en) 2013-08-09 2015-02-12 Boehringer Ingelheim International Gmbh Nebulizer
WO2015054359A1 (en) * 2013-10-08 2015-04-16 Ebadi Mark A Methods and compositions for symptomatic reflief of the common cold
US10195374B2 (en) 2014-05-07 2019-02-05 Boehringer Ingelheim International Gmbh Container, nebulizer and use
KR102492824B1 (ko) 2014-05-07 2023-01-30 베링거 인겔하임 인터내셔날 게엠베하 분무기, 표시 디바이스 및 컨테이너
WO2015169430A1 (en) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Nebulizer
CA2972177A1 (en) * 2014-12-24 2016-06-30 Jadran - Galenski Laboratorij D.D. A nasal composition containing sea water as stability-improving excipient
MX2015016549A (es) * 2015-12-02 2017-06-01 Cortés Borrego Pablo Combinacion de oximetazolina e ipratropio en aplicacion topica nasal para el tratamiento de la tos.
US20220031739A1 (en) * 2020-07-31 2022-02-03 Eye Therapies Llc Anti-viral compositions and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2137981T3 (es) * 1991-11-19 2000-01-01 Univ Virginia Tratamiento combinado por agentes antimediaticos y antiviricos de resfriados comunes.
IL101056A (en) * 1992-02-24 1997-03-18 Res & Dev Co Ltd Composition for nasal treatment
GB9218834D0 (en) 1992-09-05 1992-10-21 Procter & Gamble Nasal spray products
AU6048694A (en) 1992-12-09 1994-07-04 Paul D. Jager Stabilized medicinal aerosol solution formulations
EP0780127A1 (de) 1995-12-19 1997-06-25 The Procter & Gamble Company Nasenspray enthaltend einen Steroid und einen Antihistamin
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
JP2001524108A (ja) 1997-04-30 2001-11-27 ワーナー−ランバート・カンパニー 局所経鼻抗炎症組成物
PT1051155E (pt) * 1998-01-30 2002-10-31 Novartis Consumer Health Sa Solucoes nasais
AU759222B2 (en) 1998-06-18 2003-04-10 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
ATE232099T1 (de) * 1999-06-22 2003-02-15 Boehringer Ingelheim Int Stabile xylometazolin- und oxymetazolinlösung
HU226527B1 (hu) * 2001-09-18 2009-03-30 Nycomed Danmark Aps Készítmények nátha kezelésére

Also Published As

Publication number Publication date
CN1555263A (zh) 2004-12-15
SI1446119T1 (sl) 2006-08-31
JP4500045B2 (ja) 2010-07-14
EA008165B1 (ru) 2007-04-27
CN1290502C (zh) 2006-12-20
EA200400444A1 (ru) 2005-02-24
PL370536A1 (en) 2005-05-30
NZ531792A (en) 2006-02-24
US7652030B2 (en) 2010-01-26
JP2005505569A (ja) 2005-02-24
BR0212586A (pt) 2004-10-13
CA2460140A1 (en) 2003-03-27
US20100093783A1 (en) 2010-04-15
WO2003024433A3 (en) 2004-06-10
CA2460140C (en) 2009-09-01
NO20041070L (no) 2004-05-18
BR0212586B1 (pt) 2013-11-19
ES2259098T3 (es) 2006-09-16
US8450339B2 (en) 2013-05-28
HK1067984A1 (en) 2005-04-22
EP1446119B1 (de) 2006-03-01
EP1446119A2 (de) 2004-08-18
HU226527B1 (hu) 2009-03-30
DK1446119T3 (da) 2006-07-10
KR20040049849A (ko) 2004-06-12
US20040248924A1 (en) 2004-12-09
PT1446119E (pt) 2006-07-31
KR100810872B1 (ko) 2008-03-06
DE60209511D1 (de) 2006-04-27
HUP0402075A2 (hu) 2005-02-28
HUP0402075A3 (en) 2008-04-28
EP1661570A3 (de) 2012-10-24
MXPA04002500A (es) 2004-11-22
DE60209511T2 (de) 2006-10-05
BRPI0212586B8 (pt) 2021-05-25
NO334441B1 (no) 2014-03-03
WO2003024433A2 (en) 2003-03-27
PL208686B1 (pl) 2011-05-31
EP1661570A2 (de) 2006-05-31

Similar Documents

Publication Publication Date Title
ATE318601T1 (de) Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten
WO2005063297A3 (en) Melatonin combination therapy for improving sleep quality
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
NO2007010I1 (no) Sitagliptin, eventuelt i form av et farmasoytisk akseptabelt salt
WO2002085909A8 (en) 9-deazaguanine derivatives as inhibitors of gsk-3
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
BR0212042A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto
MXPA03011515A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos, corticoesteroides y agentes betamimeticos.
DE60043318D1 (de) Synergistische kombination von pumafentrine und salmeterol
ATE454378T1 (de) Verbindungen, die sich als inhibitoren vonjak und anderen proteinkinasen eignen
GB0223040D0 (en) Therapeutic compounds
ATE449081T1 (de) Fluoralkoxy-substituierte 1, 3-dihydro-isoindolyl-verbindungen und ihre pharmazeutischen verwendungen
BR0307508A (pt) Composto, composição farmacêutica, e, métodos de tratamento ou prevenção de dor e inflamação e de tratamento de doença
ATE402175T1 (de) 4-oxo-1-(3-substituiertesphenyl)-1,4-dihydro-1, - naphthyridin-3-carbonsäureamide alsphoshodiesterase-4-inhibitoren
MXPA03011466A (es) Macrociclos utiles en tratamiento de enfermedades de alzheimer.
RU2003127718A (ru) Применение флумазенила в производстве лекарственного средства для лечения кокаиновой зависимости
DE60117541D1 (de) Candesartan zur Behandlung von Migräne
BR0112123A (pt) Composto
ATE342720T1 (de) Kombination aus quetiapin und zolmitriptan
ATE353221T1 (de) Verwendung von gegen candida wirksamen mitteln zur behandlung von störungen der oralen und intestinalen mucosa
DE50302825D1 (de) 2-methylthiazolidin-2,4-dicarbonsaeure und deren salze zur behandlung von neurodegenerativen erkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1446119

Country of ref document: EP